SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-267743
Filing Date
2023-11-01
Accepted
2023-11-01 07:57:04
Documents
13
Period of Report
2023-11-01
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d524433d8k.htm   iXBRL 8-K 59835
  Complete submission text file 0001193125-23-267743.txt   225728

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eqrx-20231101.xsd EX-101.SCH 4402
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eqrx-20231101_def.xml EX-101.DEF 13381
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE eqrx-20231101_lab.xml EX-101.LAB 22369
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eqrx-20231101_pre.xml EX-101.PRE 14284
7 EXTRACTED XBRL INSTANCE DOCUMENT d524433d8k_htm.xml XML 5533
Mailing Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139 (617) 315-2255
EQRx, Inc. (Filer) CIK: 0001843762 (see all company filings)

IRS No.: 861691173 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40312 | Film No.: 231366612
SIC: 2834 Pharmaceutical Preparations